Under the term sheet, CRML will receive long-term offtake rights to 50% of the Tanbreez concentrate output and set out plans ...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
The UK and Germany are continuing to strengthen their long-standing scientific partnership with a significant new investment ...
New joint venture will develop neutral beams for fusion and accelerator innovations for non-fusion applications, creating high-skilled jobs and establishing a critical supply chain OXFORD, England and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback